Medical Devices

Request for TOC Request for Sample
BUY NOW

Europe Contrast Injector Market – Industry Trends and Forecast to 2028

Medical Devices | Published Report | Sep 2021 | Country Level | 350 Pages | No of Tables: 116 | No of Figures: 49

Report Description

Europe Contrast Injector Market, By product (injector systems, consumables, and accessories),application (radiology, interventional radiology, and interventional cardiology), modality (dual-head, single head, and syringeless injectors), design (pedestal mounted, ceiling mounted and standalone). end user (hospital, diagnostic imaging centers, ambulatory surgical centers, and others), distribution channel (direct tender and third party distributors). Country (Germany, France, Italy, and Spain) – Industry Trends & Forecast to 2028

Get Exclusive Sample Copy of this Report Here

Market Analysis and Insights: Europe Contrast Injector Market

Contrast injector market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.9% in the forecast period of 2021 to 2028 and is expected to reach USD 458.89 million by 2028 from USD 312.88 million in 2020. Growing geriatric population and rising per capita income; are the major drivers which propelled the demand of the market in the forecast period.

Advancement in healthcare infrastructure and increasing number of diagnostic procedures effectively help the growth of the contrast injector market. However, the lack of accessibility and high cost associated with devices may hamper the future growth of the contrast injector market. The partnerships and acquisitions by major market players act as an opportunity for the growth of Contrast injector market.

The Contrast injector market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Get Exclusive Sample Copy of this Report Here

Europe Contrast injector Market Scope and Market Size

Contrast injector market is segmented based on the basis of product, application, modality, design, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, market is segmented into injector systems, consumables, and accessories. In 2021, injector systems are dominating the market due to the rising number of diagnostic procedures.
  • On the basis of application, the market is segmented into radiology, interventional radiology, and interventional cardiology. In 2021, radiology is dominating the market due to the growing patient emphasis on effective and early disease diagnosis.
  • On the basis of modality, the market is segmented into dual-head, single head, and syringeless injectors.  In 2021, dual-head segment is dominating the market due to its multi-purpose usage of injecting both saline solutions and contrast media using a single device.
  • On the basis of design the market is segmented into pedestal mounted, ceiling mounted and standalone.  In 2021, pedestal mounted segment is dominating the market due to its movement friendly compact design.
  • On the basis of end users, the market is segmented into hospital, diagnostic imaging centers, ambulatory surgical centers, and others. In 2021, hospital segment is dominating the market due to growing number of hospitals in low and middle income countries.
  • On the basis of distribution channels, the Contrast injector market is segmented into direct tender and third-party distributors. In 2021, direct tender segment is dominating the market because direct tender holds the largest market share along with highest CAGR because most of the service providers buy the devices from manufacturers, and it is noticed that revenue from direct sales is higher; so it is influential as well as growing in the market.

Contrast injector Market Country Level Analysis

The Contrast injector market is analysed and market size information is provided by product, application, modality, design, end user, and distribution channel.

The countries covered in the Contrast injector market report are the Germany, France, Italy and Spain.

Injector systems segment in Asia-pacific region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 owing to growing usage of contrast injectors during diagnosis. China is leading country in the growth of the Asia-Pacific market due to growing geriatric population as well as technology advancement in healthcare sector. The Germany is dominating the European market owing to escalation in healthcare expenditure.  

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing strategic activities by major market players to enhance the awareness for contrast injector is boosting the market growth of contrast injector market.

Contrast injector market also provides you with detailed market analysis for every country growth in Contrast injector industry. Moreover, it provides detailed information regarding Contrast injector sales, impact of regulatory scenarios, and trending parameters regarding Contrast injector market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Contrast injector Market Share Analysis

Contrast injector market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Contrast injector market.

  • The major companies which are dealing in the Contrast injector are

Bayer AG, Guerbet, Bracco Imaging S.p.A, MEDTRON AG, Ulrich GmbH & Co.KG, Nemoto Kyrindo Co., Ltd., APOLLO RT Co. Ltd., Shenzhen Seacrown Electromechanical Co., Ltd., Shenzhen Anke High-tech Co. Ltd., SINO MDTBaslan Ltd.,AADCO Medical Inc., SCW Medicath Ltd., B. Braun Melsungen Ag, Medline Industries Inc., Shenzhan Antmed Co., Ltd., Sinton Medical Products, Radtech X-Ray, Inc., Metron Healthcare, Angiodynamics Inc. among others.

Many contracts and agreements are also initiated by the companies’ worldwide, which are also accelerating the Contrast injector market.

For instance,

  • In September 2019, Bayer AG launched its Medrad Stellant Flex CT injection system. Stellant Flex is a user-driven system that requires minimal technologist training and automation. It offers individualized patient protocols and personalized imaging with flexible options for capital equipment through its TechCare program.
  • In March 2020, ulrich medical presented a version of its CT motion contrast media injector designed for the American market. It has FDA approval and will be marketed in cooperation with partner GE Healthcare. ulrich medical already supplies its contrast media injectors to more than 60 countries. This product launch boosted the company’s existing contrast injector devices and product portfolio and helped it to attain a lucrative growth in the market.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company footprints in the Contrast injector market which also provides the benefit for organization’s profit growth.


SKU-

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF CONTRAST INJECTOR MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 COMPONENT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET APPLICATION COVERAGE GRID

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 REGULATIONS

5.1 FOOD AND DRUG ADMINISTRATION GUIDELINES

5.2 EUROPEAN MEDICAL AGENCY REGULATION

5.3 REGULATION IN CHINA

6 REGIONAL SUMMARY

6.2 EUROPE CONTRAST INJECTOR MARKET

6.2.1 OVERVIEW

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES SUCH AS CANCER AND CVD

7.1.2 GROWTH IN NUMBER OF IMAGING PROCEDURES

7.1.3 INCREASING PRODUCT APPROVAL

7.1.4 REIMBURSEMENT POLICY FOR CONTRAST MEDIA

7.2 RESTRAINTS

7.2.1 CHANGING END USER DEMAND

7.2.2 HIGH COST OF CONTRAST INJECTOR SYSTEMS

7.2.3 RISKS ASSOCIATED WITH THE USE OF CONTRAST MEDIA IN THE INJECTOR SYSTEM

7.2.4 PRODUCT RECALL

7.3 OPPORTUNITIES

7.3.1 RISING PER CAPITA INCOME AND HEALTHCARE EXPENDITURE

7.3.2 ADVANCEMENT IN TECHNOLOGY

7.3.3 COLLABORATIONS AND AGREEMENTS IN THE MARKET

7.4 CHALLENGES

7.4.1 ISSUES RELATED TO MEDICAL DEVICES HACKING

7.4.2 HIGH COST OF MRI AND CT SCAN MACHINE

7.5 IMPACT OF COVID-19 ON GLOBAL CONTRAST INJECTOR MARKET

7.6 IMPACT ON SUPPLY CHAIN

7.7 IMPACT ON DEMAND

7.8 PRICE IMPACT

7.9 STRATEGIC DECISIONS FOR MANUFACTURERS

7.1 CONCLUSION

8 CONTRAST INJECTOR MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 INJECTOR SYSTEM

8.2.1 TYPE

8.2.2 CT INJECTOR

8.2.3 MRI INJECTOR

8.2.4 ANGIOGRAPHY INJECTOR

8.3 BY MODALITY

8.3.1 DUAL-HEAD

8.3.2 SINGLE HEAD

8.3.3 SYRINGELESS INJECTOR

8.4 CONSUMABLES

8.5 ACCESSORIES

9 CONTRAST INJECTOR MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 RADIOLOGY

9.2.1 INJECTOR SYSTEMS

9.2.2 CONSUMABLES

9.2.3 ACCESSORIES

9.3 INTERVENTIONAL RADIOLOGY

9.3.1 INJECTOR SYSTEMS

9.3.2 CONSUMABLES

9.3.3 ACCESSORIES

9.4 INTERVENTIONAL CARDIOLOGY

9.4.1 INJECTOR SYSTEMS

9.4.2 CONSUMABLES

9.4.3 ACCESSORIES

10 CONTRAST INJECTOR MARKET, BY MODALITY

10.1 OVERVIEW

10.2 DUAL-HEAD

10.3 SINGLE HEAD

10.4 SYRINGELESS INJECTORS

11 CONTRAST INJECTOR MARKET, BY DESIGN

11.1 OVERVIEW

11.2 PEDESTAL MOUNTED

11.3 CEILING MOUNTED

11.4 STANDALONE

12 CONTRAST INJECTOR MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS

12.2.1 INJECTOR SYSTEMS

12.2.2 CONSUMABLES

12.2.3 ACCESSORIES

12.3 DIANGOSTIC IMAGING CENTERS

12.3.1 INJECTOR SYSTEMS

12.3.2 CONSUMABLES

12.3.3 ACCESSORIES

12.4 AMBULATORY SURGICAL CENTERS

12.4.1 INJECTOR SYSTEMS

12.4.2 CONSUMABLES

12.4.3 ACCESSORIES

12.5 OTHERS

13 CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDER

13.3 THIRD PARTY DISTRIBUTORS

14 CONTRAST INJECTOR MARKET, BY REGION

14.1 EUROPE

14.1.1 GERMANY

14.1.2 FRANCE

14.1.3 ITALY

14.1.4 SPAIN

15 CONTRAST INJECTOR MARKET: COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: EUROPE

16 SWOT ANALYSIS

17 COMPANY PROFILE

17.1 BAYER AG

17.1.1 COMPANY SNAPSHOT

17.1.2 REVENUE ANALYSIS

17.1.3 COMPANY SHARE ANALYSIS

17.1.4 PRODUCT PORTFOLIO

17.1.5 RECENT DEVELOPMENTS

17.2 BRACCO IMAGING SPA

17.2.1 COMPANY SNAPSHOT

17.2.2 COMPANY SHARE ANALYSIS

17.2.3 PRODUCT PORTFOLIO

17.2.4 RECENT DEVELOPMENTS

17.3 GUERBET

17.3.1 COMPANY SNAPSHOT

17.3.2 REVENUE ANALYSIS

17.3.3 COMPANY SHARE ANALYSIS

17.3.4 PRODUCT PORTFOLIO

17.3.5 RECENT DEVELOPMENTS

17.4 NEMOTO KYORINDO CO., LTD

17.4.1 COMPANY SNAPSHOT

17.4.2 COMPANY SHARE ANALYSIS

17.4.3 PRODUCT PORTFOLIO

17.4.4 RECENT DEVELOPMENT

17.5 ULRICH GMBH & CO.KG

17.5.1 COMPANY SNAPSHOT

17.5.2 COMPANY SHARE ANALYSIS

17.5.3 PRODUCT PORTFOLIO

17.5.4 RECENT DEVELOPMENTS

17.6 MEDTRON AG

17.6.1 COMPANY SNAPSHOT

17.6.2 PRODUCT PORTFOLIO

17.6.3 RECENT DEVELOPMENTS

17.7 AADCO MEDICAL, INC.

17.7.1 COMPANY SNAPSHOT

17.7.2 PRODUCT PORTFOLIO

17.7.3 RECENT DEVELOPMENT

17.8 ANGIODYNAMICS

17.8.1 COMPANY SNAPSHOT

17.8.2 REVENUE ANALYSIS

17.8.3 PRODUCT PORTFOLIO

17.8.4 RECENT DEVELOPMENTS

17.9 APOLLO RT CO.LTD

17.9.1 COMPANY SNAPSHOT

17.9.2 PRODUCT PORTFOLIO

17.9.3 RECENT DEVELOPMENTS

17.1 BASLAN LTD.

17.10.1 COMPANY SNAPSHOT

17.10.2 PRODUCT PORTFOLIO

17.10.3 RECENT DEVELOPMENT

17.11 B.BRAUN MELSUNGEN AG

17.11.1 COMPANY SNAPSHOT

17.11.2 REVENUE ANALYSIS

17.11.3 PRODUCT PORTFOLIO

17.11.4 RECENT DEVELOPMENT

17.12 MEDLINE INDUSTRIES, INC.

17.12.1 COMPANY SNAPSHOT

17.12.2 PRODUCT PORTFOLIO

17.12.3 RECENT DEVELOPMENTS

17.13 METRON HEALTHCARE

17.13.1 COMPANY SNAPSHOT

17.13.2 PRODUCT PORTFOLIO

17.13.3 RECENT DEVELOPMENTS

17.14 RADTECH X-RAY, INC.

17.14.1 COMPANY SNAPSHOT

17.14.2 PRODUCT PORTFOLIO

17.14.3 RECENT DEVELOPMENT

17.15 SCW MEDICATH LTD.

17.15.1 COMPANY SNAPSHOT

17.15.2 PRODUCT PORTFOLIO

17.15.3 RECENT DEVELOPMENTS

17.16 SHENZHEN ANKE HIGH-TECH

17.16.1 COMPANY SNAPSHOT

17.16.2 PRODUCT PORTFOLIO

17.16.3 RECENT DEVELOPMENTS

17.17 SHENZHEN ANTMED CO., LTD

17.17.1 COMPANY SNAPSHOT

17.17.2 PRODUCT PORTFOLIO

17.17.3 RECENT DEVELOPMENTS

17.18 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD

17.18.1 COMPANY SNAPSHOT

17.18.2 PRODUCT PORTFOLIO

17.18.3 RECENT DEVELOPMENTS

17.19 SINO MDT

17.19.1 COMPANY SNAPSHOT

17.19.2 PRODUCT PORTFOLIO

17.19.3 RECENT DEVELOPMENT

17.2 SINTON MEDICAL PRODUCT

17.20.1 COMPANY SNAPSHOT

17.20.2 PRODUCT PORTFOLIO

17.20.3 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS

List of Table

TABLE 1 PER CAPITA AMOUNTS: UNITED STATES (1960–2017 YEARS)

TABLE 2 CONTRAST INJECTOR MARKET, BY PRODUCT, 2019–2028 (USD MILLION)

TABLE 3 INJECTOR SYSTEM IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 4 INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 5 INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (UNITS)

TABLE 6 INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (INSTALLED BASED)

TABLE 7 INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 8 CONSUMABLES IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 ACCESSORIES IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 11 RADIOLOGY IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 13 INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 15 INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 17 CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 18 DUAL-HEAD IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 SINGLE HEAD IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 SYRINGELESS INJECTORS IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 CONTRAST INJECTOR MARKET, BY DESIGN, 2019-2028 (USD MILLION)

TABLE 22 PEDESTAL MOUNTED IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 CEILING MOUNTED IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 STANDALONE IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 26 HOSPITALS IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 HOSPITALS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 28 DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 30 AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 32 OTHERS IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 34 DIRECT TENDER IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 THIRD PARTY DISTRIBUTORS IN CONTRAST INJECTOR MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 EUROPE CONTRAST INJECTOR MARKET, BY COUNTRY, 2019-2028 (USD MILLION )

TABLE 37 EUROPE CONTRAST INJECTOR MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 38 EUROPE INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 39 EUROPE INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (UNITS)

TABLE 40 EUROPE INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (INSTALLED BASED)

TABLE 41 EUROPE INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 42 EUROPE CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 43 EUROPE RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 44 EUROPE INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 45 EUROPE INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 46 EUROPE CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 47 EUROPE CONTRAST INJECTOR MARKET, BY DESIGN, 2019-2028 (USD MILLION)

TABLE 48 EUROPE CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 49 EUROPE HOSPITALS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 50 EUROPE DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 51 EUROPE AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 EUROPE CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 53 GERMANY CONTRAST INJECTOR MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 54 GERMANY INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 55 GERMANY INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (UNITS)

TABLE 56 GERMANY INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (INSTALLED BASED)

TABLE 57 GERMANY INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 58 GERMANY CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 59 GERMANY RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 60 GERMANY INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 61 GERMANY INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 62 GERMANY CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 63 GERMANY CONTRAST INJECTOR MARKET, BY DESIGN, 2019-2028 (USD MILLION)

TABLE 64 GERMANY CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 65 GERMANY HOSPITALS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 66 GERMANY DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 67 GERMANY AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 68 GERMANY CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 69 FRANCE CONTRAST INJECTOR MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 70 FRANCE INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 71 FRANCE INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (UNITS)

TABLE 72 FRANCE INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (INSTALLED BASED)

TABLE 73 FRANCE INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 74 FRANCE CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 75 FRANCE RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 76 FRANCE INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 77 FRANCE INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 78 FRANCE CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 79 FRANCE CONTRAST INJECTOR MARKET, BY DESIGN, 2019-2028 (USD MILLION)

TABLE 80 FRANCE CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 81 FRANCE HOSPITALS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 82 FRANCE DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 83 FRANCE AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 84 FRANCE CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 85 ITALY CONTRAST INJECTOR MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 86 ITALY INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 87 ITALY INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (UNITS)

TABLE 88 ITALY INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (INSTALLED BASED)

TABLE 89 ITALY INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 90 ITALY CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 91 ITALY RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 92 ITALY INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 93 ITALY INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 94 ITALY CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 95 ITALY CONTRAST INJECTOR MARKET, BY DESIGN, 2019-2028 (USD MILLION)

TABLE 96 ITALY CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 97 ITALY HOSPITALS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 98 ITALY DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 99 ITALY AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 100 ITALY CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 101 SPAIN CONTRAST INJECTOR MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 102 SPAIN INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 103 SPAIN INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (UNITS)

TABLE 104 SPAIN INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY TYPE, 2019-2028 (INSTALLED BASED)

TABLE 105 SPAIN INJECTOR SYSTEMS IN CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 106 SPAIN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 107 SPAIN RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 108 SPAIN INTERVENTIONAL RADIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 109 SPAIN INTERVENTIONAL CARDIOLOGY IN CONTRAST INJECTOR MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 110 SPAIN CONTRAST INJECTOR MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 111 SPAIN CONTRAST INJECTOR MARKET, BY DESIGN, 2019-2028 (USD MILLION)

TABLE 112 SPAIN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 113 SPAIN HOSPITALS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 114 SPAIN DIAGNOSTIC IMAGING CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 115 SPAIN AMBULATORY SURGICAL CENTERS IN CONTRAST INJECTOR MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 116 SPAIN CONTRAST INJECTOR MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

List of Figure

FIGURE 1 CONTRAST INJECTOR MARKET: SEGMENTATION

FIGURE 2 CONTRAST INJECTOR MARKET: DATA TRIANGULATION

FIGURE 3 CONTRAST INJECTOR MARKET: DROC ANALYSIS

FIGURE 4 CONTRAST INJECTOR MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 CONTRAST INJECTOR MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 CONTRAST INJECTOR MARKET: MULTIVARIATE MODELLING

FIGURE 7 CONTRAST INJECTOR MARKET: COMPONENT TYPE LIFELINE CURVE

FIGURE 8 CONTRAST INJECTOR MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 9 CONTRAST INJECTOR MARKET: DBMR MARKET POSITION GRID

FIGURE 10 CONTRAST INJECTOR MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 CONTRAST INJECTOR MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 12 CONTRAST INJECTOR MARKET: SEGMENTATION

FIGURE 13 U.S. IS EXPECTED TO DOMINATE THE CONTRAST INJECTOR MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 INCREASING PREVALENCE OF CHRONIC DISEASES AND GROWTH IN NUMBER OF IMAGING PROCEDURES IS EXPECTED TO DRIVE THE GROWTH OF CONTRAST INJECTOR MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 15 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE CONTRAST INJECTOR MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 16 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR THE CONTRAST INJECTOR MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF CONTRAST INJECTOR MARKET

FIGURE 18 ESTIMATED NUMBER OF NEW CASES IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES

FIGURE 19 IMAGING RATE IN U.S. (RATE PER 1000 PERSON/YEAR)

FIGURE 20 CONTRAST INJECTOR MARKET: BY PRODUCT , 2020

FIGURE 21 CONTRAST INJECTOR MARKET: BY PRODUCT , 2021-2028 (USD MILLION)

FIGURE 22 CONTRAST INJECTOR MARKET: BY PRODUCT , CAGR (2021-2028)

FIGURE 23 CONTRAST INJECTOR MARKET: BY PRODUCT , LIFELINE CURVE

FIGURE 24 CONTRAST INJECTOR MARKET: BY APPLICATION, 2020

FIGURE 25 CONTRAST INJECTOR MARKET: BY PRODUCT, 2021-2028 (USD MILLION)

FIGURE 26 CONTRAST INJECTOR MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 27 CONTRAST INJECTOR MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 28 CONTRAST INJECTOR MARKET: BY MODALITY, 2020

FIGURE 29 CONTRAST INJECTOR MARKET: BY MODALITY, 2021-2028 (USD MILLION)

FIGURE 30 CONTRAST INJECTOR MARKET: BY MODALITY, CAGR (2021-2028)

FIGURE 31 CONTRAST INJECTOR MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 32 CONTRAST INJECTOR MARKET: BY DESIGN, 2020

FIGURE 33 CONTRAST INJECTOR MARKET: BY DESIGN, 2021-2028 (USD MILLION)

FIGURE 34 CONTRAST INJECTOR MARKET: BY DESIGN, CAGR (2021-2028)

FIGURE 35 CONTRAST INJECTOR MARKET: BY DESIGN, LIFELINE CURVE

FIGURE 36 CONTRAST INJECTOR MARKET: BY END USER, 2020

FIGURE 37 CONTRAST INJECTOR MARKET: BY END USER, 2021-2028 (USD MILLION)

FIGURE 38 CONTRAST INJECTOR MARKET: BY END USER, CAGR (2021-2028)

FIGURE 39 CONTRAST INJECTOR MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 CONTRAST INJECTOR MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 41 CONTRAST INJECTOR MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 42 CONTRAST INJECTOR MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 43 CONTRAST INJECTOR MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 EUROPE CONTRAST INJECTOR MARKET: SNAPSHOT (2020)

FIGURE 45 EUROPE CONTRAST INJECTOR MARKET: BY COUNTRY (2020)

FIGURE 46 EUROPE CONTRAST INJECTOR MARKET: BY COUNTRY (2021 & 2028)

FIGURE 47 EUROPE CONTRAST INJECTOR MARKET: BY COUNTRY (2020 & 2028)

FIGURE 48 EUROPE CONTRAST INJECTOR MARKET: BY PRODUCT (2021-2028)

FIGURE 49 EUROPE CONTRAST INJECTOR MARKET: COMPANY SHARE 2020 (%)

View Infographics

FIGURE 1 CONTRAST INJECTOR MARKET: SEGMENTATION

FIGURE 2 CONTRAST INJECTOR MARKET: DATA TRIANGULATION

FIGURE 3 CONTRAST INJECTOR MARKET: DROC ANALYSIS

FIGURE 4 CONTRAST INJECTOR MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 CONTRAST INJECTOR MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 CONTRAST INJECTOR MARKET: MULTIVARIATE MODELLING

FIGURE 7 CONTRAST INJECTOR MARKET: COMPONENT TYPE LIFELINE CURVE

FIGURE 8 CONTRAST INJECTOR MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 9 CONTRAST INJECTOR MARKET: DBMR MARKET POSITION GRID

FIGURE 10 CONTRAST INJECTOR MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 CONTRAST INJECTOR MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 12 CONTRAST INJECTOR MARKET: SEGMENTATION

FIGURE 13 U.S. IS EXPECTED TO DOMINATE THE CONTRAST INJECTOR MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 INCREASING PREVALENCE OF CHRONIC DISEASES AND GROWTH IN NUMBER OF IMAGING PROCEDURES IS EXPECTED TO DRIVE THE GROWTH OF CONTRAST INJECTOR MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 15 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE CONTRAST INJECTOR MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 16 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR THE CONTRAST INJECTOR MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF CONTRAST INJECTOR MARKET

FIGURE 18 ESTIMATED NUMBER OF NEW CASES IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES

FIGURE 19 IMAGING RATE IN U.S. (RATE PER 1000 PERSON/YEAR)

FIGURE 20 CONTRAST INJECTOR MARKET: BY PRODUCT , 2020

FIGURE 21 CONTRAST INJECTOR MARKET: BY PRODUCT , 2021-2028 (USD MILLION)

FIGURE 22 CONTRAST INJECTOR MARKET: BY PRODUCT , CAGR (2021-2028)

FIGURE 23 CONTRAST INJECTOR MARKET: BY PRODUCT , LIFELINE CURVE

FIGURE 24 CONTRAST INJECTOR MARKET: BY APPLICATION, 2020

FIGURE 25 CONTRAST INJECTOR MARKET: BY PRODUCT, 2021-2028 (USD MILLION)

FIGURE 26 CONTRAST INJECTOR MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 27 CONTRAST INJECTOR MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 28 CONTRAST INJECTOR MARKET: BY MODALITY, 2020

FIGURE 29 CONTRAST INJECTOR MARKET: BY MODALITY, 2021-2028 (USD MILLION)

FIGURE 30 CONTRAST INJECTOR MARKET: BY MODALITY, CAGR (2021-2028)

FIGURE 31 CONTRAST INJECTOR MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 32 CONTRAST INJECTOR MARKET: BY DESIGN, 2020

FIGURE 33 CONTRAST INJECTOR MARKET: BY DESIGN, 2021-2028 (USD MILLION)

FIGURE 34 CONTRAST INJECTOR MARKET: BY DESIGN, CAGR (2021-2028)

FIGURE 35 CONTRAST INJECTOR MARKET: BY DESIGN, LIFELINE CURVE

FIGURE 36 CONTRAST INJECTOR MARKET: BY END USER, 2020

FIGURE 37 CONTRAST INJECTOR MARKET: BY END USER, 2021-2028 (USD MILLION)

FIGURE 38 CONTRAST INJECTOR MARKET: BY END USER, CAGR (2021-2028)

FIGURE 39 CONTRAST INJECTOR MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 CONTRAST INJECTOR MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 41 CONTRAST INJECTOR MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 42 CONTRAST INJECTOR MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 43 CONTRAST INJECTOR MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 EUROPE CONTRAST INJECTOR MARKET: SNAPSHOT (2020)

FIGURE 45 EUROPE CONTRAST INJECTOR MARKET: BY COUNTRY (2020)

FIGURE 46 EUROPE CONTRAST INJECTOR MARKET: BY COUNTRY (2021 & 2028)

FIGURE 47 EUROPE CONTRAST INJECTOR MARKET: BY COUNTRY (2020 & 2028)

FIGURE 48 EUROPE CONTRAST INJECTOR MARKET: BY PRODUCT (2021-2028)

FIGURE 49 EUROPE CONTRAST INJECTOR MARKET: COMPANY SHARE 2020 (%)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19